NURS 6630 Midterm Exam Latest 2021/2022 questions with answers

nurs663




NURS 6630 Midterm Exam

Question1 1
out of 1 points
When an unstable patient asks why it is necessary to add
medications to his current regimen, the PMHNP’s best response
would be:

Selected C.
Answer: “Many psychiatric illnesses involve several dys-functioning neurotransmitter systems in
the brain. Often, a single medication may only effect one or two of the dys-functioning
systems. The addition of another medication can work with the current medication in
stabilizing multiple neurotransmitter systems and help to alleviate your symptoms.”
 Question 2
0 out of 1 points
The PMHNP is meeting with a new mother who would like to begin
taking medication again to treat her bipolar depression; she is
breastfeeding her 2-month old daughter. The PMHNP recognizes
that which of the following medications is contraindicated for this
patient?

Selected C.
Answer: Lithium
(Lithobid)
 Question 3
1 out of 1 points
Mr. Gordon is a middle-aged client who was started on antidepressant
monotherapy for depression. After beginning this medication, the PMHNP
noticed that this client seemed to swing into a hypomanic episode. What can
the PMHNP infer from this behavior change?
Selected A.
Answer: This client may have Bipolar III disorder
 Question 4
1 out of 1 points
A patient presents with frequent episodes of mania. Which
statement describes an appropriate treatment approach for this
patient?

Selected B.
Answer: “The patient could benefit from an

, anticonvulsant.”
 Question 5
1 out of 1 points
The student inquires about antipsychotic medications. Which
response by the PMHNP describes the factors that contribute to
reduced risk of extrapyramidal symptoms (EPS) for patients who
take antipsychotics?

Selected B.
Answer: Those that are potent D2 antagonists with 5HT2A
antagonism properties
 Question 6
1 out of 1 points
After ordering flumazenil (Rumazicon) the PMHNP cautions the staff to monitor for
which possible effect?
Selected D.
Answer: All of the
above
 Question 7
1 out of 1 points
The PMHNP is caring for a patient who is taking antipsychotics
heard the psychiatrist tell the patient that the patient would be
placed on a different antipsychotic agent called an atypical
antipsychotic. What neurotransmitters will this new medication work on?
Selected A.
Answer: dopamine and serotonin
 Question 8
1 out of 1 points
While genes have potential to modify behavior, behavior can also
modify genes. How do genes impact this process?

Selected B.
Answer: Changes made to proteins lead to changes in
behavior.
 Question 9
1 out of 1 points
Mrs. Schwartzman is a 52-year-old client with schizophrenia and no
established history of depression. When meeting with the PMHNP, she
presents with apathy and withdrawn social behavior, and she reports a loss
of joy from enjoyable activities since starting her new medication. What does

, the PMHNP infer from this encounter with the client?
Selected C.
Answer: The new medication is blocking D2 receptors in the mesolimbic
system
 Question 10
1 out of 1 points
A nursing student is seeking clarification on the use of
anticonvulsants to treat depression and is unclear about most
effective outcomes. Which of the following agents does the PMHNP
convey as having uncertain outcomes?

Selected B.
Answer: Gabapentin
(Neurontin)
 Question 11
1 out of 1 points
As it relates to G-protein linked receptors, what does the PMHNP
understand about medications that are used in practice?

Selected A.
Answer: Most medications that act on G-protein linked
receptors have antagonistic traits.
 Question 12
1 out of 1 points
A patient is seeking pharmacological treatment for smoking
cessation. Which drug class does the PMHNP prescribe to the
patient?

Selected D.
Answer: Varenicline
(Chantix)
 Question 13
1 out of 1 points
The PMHNP is caring for a patient with schizophrenia and is
considering a variety of treatment approaches. The PHMNP selects
a viable treatment that is consistent with the “dopamine
hypothesis of schizophrenia.” What action does the PMHNP
anticipate this treatment having on the patient?

Selected B.
Answer:

, Hyperactivity in the mesolimbic dopamine pathway
mediates the positive symptoms of schizophrenia.
 Question 14
1 out of 1 points
Though medications have the ability to target neurotransmitter release into
the synapse by the presynaptic neuron it is not always necessary. The PMHNP
understands that this is because:
Selected C.
Answer: Neurotransmitters can spread by
diffusion.
 Question 15
1 out of 1 points
A patient is being prescribed a sedating antidepressant, but is
concerned about weight gain. Which medication is most likely to be
prescribed to addresses the patient’s concerns?

Selected D.
Answer: trazadone
(Oleptro)
 Question 16
1 out of 1 points
The PMHNP is caring for several patients who present with various
symptoms and health issues. For which patient does the PMHNP
prescribe pregabalin (Lyrica)?

Selected B.
Answer: Patient with partial
seizures
 Question 17
1 out of 1 points
Which statement about neurotransmitters and medications is true?

Selected B.
Answer: Several psychiatric medications have been developed after discoveries of endogenous
neurotransmitters and defining their function in the brain .
 Question 18
1 out of 1 points
A patient is prescribed 50 mg of desvenlafaxine to take every other
day for major depressive disorder. What does the PMHNP